BamSEC and AlphaSense Join Forces
Learn More

Zevra Therapeutics Inc.

NASDAQ: ZVRA    
Share price (1/7/25): $8.24    
Market cap (1/7/25): $440 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K 14 pages Amended and Restated Bylaws of Zevra Therapeutics, Inc. February 22, 2024
12/34/56
EX-3.2
from 8-K 14 pages Amended and Restated Bylaws of Zevra Therapeutics, Inc. (A Delaware Corporation) February 21, 2023 Zevra Therapeutics, Inc. Amended and Restated Bylaws
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment of Amended and Restated Certificate of Incorporation of Kempharm, Inc
12/34/56
EX-3.3
from 8-K 2 pages Certificate of Elimination of Series B-2 Convertible Preferred Stock of Kempharm, Inc. (Pursuant to Section 151(g) of the General Corporation Law of the State of Delaware) 1
12/34/56
EX-3.2
from 8-K 2 pages Certificate of Elimination of Series B-1 Convertible Preferred Stock of Kempharm, Inc. (Pursuant to Section 151(g) of the General Corporation Law of the State of Delaware) 1
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Elimination of Series a Convertible Preferred Stock of Kempharm, Inc. (Pursuant to Section 151(g) of the General Corporation Law of the State of Delaware) 1
12/34/56
EX-3.1
from 8-K 22 pages Kempharm, Inc. Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of Series B-2 Convertible Preferred Stock Pursuant to Section 151(g) of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment of Amended and Restated Certificate of Incorporation of Kempharm, Inc
12/34/56
EX-3.1
from 8-K 22 pages Kempharm, Inc. Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of Series B-2 Convertible Preferred Stock Pursuant to Section 151(g) of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 2 pages Kempharm, Inc. Certificate of Amendment to Certificate of Designation of Preferences, Rights and Limitations of Series B-2 Convertible Preferred Stock Pursuant to Section 151(g) of the Delaware General Corporation Law [Remainder of This Page Intentionally Left Blank]
12/34/56
EX-3.2
from 8-K 20 pages Kempharm, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series B-2 Convertible Preferred Stock Pursuant to Section 151(g) of the Delaware General Corporation Law Series B-2 Convertible Preferred Stock
12/34/56
EX-3.1
from 8-K 20 pages Kempharm, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series B-1 Convertible Preferred Stock Pursuant to Section 151(g) of the Delaware General Corporation Law Series B-1 Convertible Preferred Stock
12/34/56
EX-3.1
from 8-K 18 pages Kempharm, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series a Convertible Preferred Stock Pursuant to Section 151(g) of the Delaware General Corporation Law Series a Convertible Preferred Stock
12/34/56
EX-3.2
from 8-K 25 pages Amended and Restated Bylaws of Kempharm, Inc. (A Delaware Corporation) April 21, 2015 Kempharm, Inc. Amended and Restated Bylaws
12/34/56
EX-3.1
from 8-K 5 pages Kempharm, Inc. Amended and Restated Certificate of Incorporation * * * *
12/34/56
EX-3.3
from S-1/A 5 pages Kempharm, Inc. Amended and Restated Certificate of Incorporation I
12/34/56
EX-3.2
from S-1/A 2 pages Certificate of Amendment to the Certificate of Incorporation of Kempharm, Inc
12/34/56
EX-3.5
from S-1 25 pages Amended and Restated Bylaws of Kempharm, Inc. (A Delaware Corporation) Kempharm, Inc. Amended and Restated Bylaws
12/34/56
EX-3.4
from S-1 13 pages Bylaws of Kempharm, Inc. Article 1 Offices
12/34/56
EX-3.3
from S-1 5 pages Kempharm, Inc. Amended and Restated Certificate of Incorporation I
12/34/56